Arcadia Biosciences, Inc.
RKDA· Nasdaq
Released Aug 13, 2019, after the close
10-Q filed Aug 14, 2019, 45 days after period end · 0001564590-19-032192
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $203.00K | $436.00K | $991.00K | $721.00K |
| Net Income | $4.24M | -$6.67M | -$4.01M | -$4.55M |
| EPS Diluted |
Arcadia Biosciences, Inc. · CIK 1469443 · Engraved from SEC EDGAR
| $0.84 |
| -$2.02 |
| -$1.88 |
| -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.